Dr. Gurkamal Chatta MD Hematologist

Dr. Gurkamal Chatta is a hematologist in Pittsburgh, Pennsylvania and is affiliated with Virginia Mason Medical Center. He received his medical degree from Delhi University College of Medical Sciences and has been in practice for 35 years. Dr. Chatta accepts several types of health insurance, listed below. He is one of 11 doctors at Virginia Mason Medical Center who specialize in Hematology.

Are you Dr. Chatta? Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: Myeloproliferative Disorder Hematology-Oncology

Hospital Affiliation

Virginia Mason Medical Center
High performing in Cancer

Education & Medical Training

Cardinal Glennon Child Hospital
Residency, Pediatrics, 1985–1985

Sinai Samaritan Medical Center
Residency, Internal Medicine, 1986–1988

University of Washington
Fellowship, Geriatric Medicine, 1988–1992

University of Washington
Fellowship, Hematology, 1995–1996

Delhi University College of Medical Sciences
Class of 1979

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Geriatric Medicine

American Board of Internal Medicine
Certified in Medical Oncology

WA State Medical License
Active through 2015

PA State Medical License
Active through 2014

Publications & Presentations

A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.
Twardowski, P. W.,Beumer, J. H.,Chen, C. S.,Kraft, A. S.,Chatta, G. S.,Mitsuhashi, M.,Ye, W.,Christner, S. M.,Lilly, M. B.

A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.
Ward, J. E., Karrison, T., Chatta, G., Hussain, M., Shevrin, D., Szmulewitz, R. Z., O'Donnell, P. H., Stadler, W. M., Posadas, E. M.

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).
Kucuk, O., Fisher, E., Moinpour, C. M., Coleman, D., Hussain, M. H., Sartor, A. O., Chatta, G. S., Lowe, B. A., Eisenberger, M. A., Crawford, E. D.

See all 47 publications

Insurances Accepted

  • Aetna Choice POS II
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Premera BCBS Heritage & Heritage Plus 1
  • Regence Washington - Preferred Provider Network
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Hematologists

See all Hematologists near Pittsburgh, PA See all Hematologists in Pennsylvania

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.